Gruis Kirsten L 4
4 · DiaMedica Therapeutics Inc. · Filed Jan 5, 2022
Insider Transaction Report
Form 4
Gruis Kirsten L
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-03+160,000→ 160,000 totalExercise: $3.88Exp: 2032-01-02→ Common Shares (160,000 underlying)
Holdings
- 0
Voting Common Shares, no par value per share
Footnotes (1)
- [F1]This option vests with respect to 40,000 common shares on January 3, 2023 and with respect to the remaining 75% of the common shares in 36 nearly equal monthly installments commencing one month after the one-year anniversary of the grant date.